Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease: a Prospective, Randomized, Crossover Study The CLEAR-IBD Trial (Colorectal Lesion Evaluation Assisted by Real-time AI in Inflammatory Bowel Disease)

NCT07694362 is registered in ClinicalTrials.gov with Vall d'Hebron Institute Research as lead sponsor.

NCT NCT07694362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07694362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease: a Prospective, Randomized, Crossover Study The CLEAR-IBD Trial (Colorectal Lesion Evaluation Assisted by Real-time AI in Inflammatory Bowel Disease)
Lead sponsor
Vall d'Hebron Institute Research
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2025
Completion date
March 1, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), chromoendoscopy, colonic dysplasia/adenomata, crohn's disease colon, inflammatory bowel disease (crohn's disease and ulcerative colitis), nbi, surveillance colonoscopy, ulcerative colitis (uc)